Hematinics: Evaluation and Management of Hematologic Disorders
Initial Evaluation
Begin with a complete blood count (CBC) to assess all three cell lines—white blood cells, hemoglobin, and platelets—as abnormalities in two or more cell lines warrant hematology consultation 1.
For Anemia Evaluation
Use hemoglobin rather than hematocrit as it is more reproducible across laboratories and unaffected by storage time or patient variables like serum glucose 1.
Key diagnostic tests to order immediately:
- Complete blood count with differential - identifies pancytopenia requiring specialist referral
- Reticulocyte count - distinguishes between production defects (low reticulocyte count) versus hemolysis/bleeding (elevated reticulocytes) 1
- Iron studies: serum ferritin and transferrin saturation 1
- Mean corpuscular volume (MCV) - low MCV suggests iron, folate, or B12 deficiency 1
For suspected hemolysis, add:
- Lactate dehydrogenase (LDH) - elevated in intravascular hemolysis 2
- Haptoglobin - reduced in hemolysis 2
- Unconjugated bilirubin - elevated in hemolysis 2
- Direct antiglobulin test (DAT/Coombs) - positive in autoimmune hemolytic anemia 2
- Blood smear examination - essential for membrane defects and thrombotic microangiopathies 2
For Thrombocytopenia Evaluation
First, exclude pseudothrombocytopenia by repeating the platelet count in a heparin or sodium citrate tube 3. This is critical as EDTA-induced platelet clumping causes false-positive results.
Determine if thrombocytopenia is acute or chronic by reviewing previous platelet counts 3. Acute thrombocytopenia may require hospitalization.
Emergency causes requiring immediate hospitalization:
- Heparin-induced thrombocytopenia (HIT) - occurs in up to 1% of patients on unfractionated heparin 4
- Thrombotic microangiopathies (TMA/TTP) - do not transfuse platelets in TTP 5
- HELLP syndrome in pregnancy 3
- Disseminated intravascular coagulation 4
Risk Stratification by Platelet Count
- >50 × 10³/μL: Generally asymptomatic, no bleeding risk 3
- 20-50 × 10³/μL: Mild skin manifestations (petechiae, purpura, ecchymosis) 3
- <10 × 10³/μL: High risk of serious bleeding 3
Management Approach
Anemia Management
In CKD patients, screen annually for anemia at minimum 1. More frequent monitoring is needed in diabetics who develop anemia at earlier CKD stages.
Iron deficiency in non-dialysis CKD patients without menstrual losses requires gastrointestinal bleeding evaluation 1.
Low reticulocyte count despite adequate iron, folate, and B12 indicates either insufficient erythropoietin production or inflammation 1. Note that 20-40% of autoimmune hemolytic anemia cases present with reticulocytopenia, which is a poor prognostic factor 2.
Thrombocytopenia Management
For isolated thrombocytopenia without systemic illness, the most likely diagnoses are immune thrombocytopenia (ITP) or drug-induced thrombocytopenia 3.
Platelet transfusion indications:
- Active hemorrhage at any platelet count 3, 6
- Prophylactic transfusion when platelets <10-20 × 10³/μL 3, 4
- Pre-procedure transfusion when platelets <50 × 10³/μL 3, 4
- Exception: Never transfuse platelets in ITP or TTP 5, 4
For ITP specifically:
- First-line treatment is corticosteroids, but prolonged use is discouraged 7
- Second-line options include thrombopoietin receptor agonists (TPO-RAs) 7
- Delay splenectomy until 12 months when possible 7
Activity Restrictions
Patients with platelets <50 × 10³/μL should avoid trauma-associated activities 3.
Critical Pitfalls to Avoid
Do not assume anemia in CKD is solely due to erythropoietin deficiency - CKD anemia is normochromic/normocytic and indistinguishable from other chronic conditions 1
Recognize that some thrombocytopenic conditions cause both bleeding AND thrombosis: antiphospholipid syndrome, HIT, and thrombotic microangiopathies 3
Early platelet transfusion in TTP is contraindicated 5
Hemolytic markers can be elevated in non-hemolytic conditions - comprehensive clinical evaluation is essential 2
Acute hemolysis can be mistaken for blood loss anemia - always check reticulocyte count and hemolytic markers 5